Roche Holding AG RHHBY 0.51% is nearing a deal to buy Philadelphia biotechnology company Spark Therapeutics Inc., according to people familiar with the matter, as the Swiss drugmaker seeks to expand its presence treating hemophilia.
top of page
THE LEADER IN BREAKING BLEEDING DISORDER NEWS
bottom of page